Biology Reference
In-Depth Information
Fortunato EA, McElroy AK, Sanchez I, Spector DH (2000) Exploitation of cellular signaling and
regulatory pathways by human cytomegalovirus. Trends Microbiol 8:111-119
Gerondakis S, Grumont R, Rourke I, Grossmann M (1998) The regulation and roles of Rel/NF-
kappa B transcription factors during lymphocyte activation. Curr Opin Immunol 10:353-359
Gredmark S, Britt WB, Xie X, Lindbom L, Soderberg-Naucler C (2004) Human cytomegalovirus
induces inhibition of macrophage differentiation by binding to human aminopeptidase N/CD13.
J Immunol 173:4897-4907
Grundy JE, McKeating JA, Griffiths PD (1987a) Cytomegalovirus strain AD169 binds beta 2
microglobulin in vitro after release from cells. J Gen Virol 68:777-784
Grundy JE, McKeating JA, Ward PJ, Sanderson AR, Griffiths PD (1987b) Beta 2 microglobulin
enhances the infectivity of cytomegalovirus and when bound to the virus enables class I HLA
molecules to be used as a virus receptor. J Gen Virol 68):793-803
Hayden MS, West AP, Ghosh S (2006) NF-kappaB and the immune response. Oncogene
25:6758-6780
Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdorfer B, Giese T, Endres S, Hartmann G
(2002) Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human
peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol
168:4531-4537
Huber MT, Compton T (1997) Characterization of a novel third member of the human cytomega-
lovirus glycoprotein H-glycoprotein L complex. J Virol 71:5391-5398
Huber MT, Compton T (1998) The human cytomegalovirus UL74 gene encodes the third compo-
nent of the glycoprotein H-glycoprotein L-containing envelope complex. J Virol
72:8191-8197
Isaacson MK, Feire AL, Compton T (2007) The epidermal growth factor receptor is not required
for human cytomegalovirus entry or signaling. J Virol 81:6241-6247
Janeway CA Jr, Medzhitov R (2002) Innate immune recognition. Annu Rev Immunol 20:197-216
Kari B, Gehrz R (1992) A human cytomegalovirus glycoprotein complex designated gC-II is a
major heparin-binding component of the envelope. J Virol 66:1761-1764
Kari B, Gehrz R (1993) Structure, composition and heparin binding properties of a human
cytomegalovirus glycoprotein complex designated gC-II. J Gen Virol 74:255-264
Keay S, Baldwin B (1991) Anti-idiotype antibodies that mimic gp86 of human cytomegalovirus
inhibit viral fusion but not attachment. J Virol 65:5124-5128
Keay S, Baldwin B (1995) Update on the 92.5 kDa putative HCMV fusion receptor. Scand J Infect
Dis Suppl 99:32-33
Keay S, Baldwin BR, Smith MW, Wasserman SS, Goldman WF (1995) Increases in [Ca2+]i medi-
ated by the 92.5-kDa putative cell membrane receptor for HCMV gp86. Am J Physiol 269:
C11-C21
Krug A, French AR, Barchet W, Fischer JA, Dzionek A, Pingel JT, Orihuela MM, Akira S,
Yokoyama WM, Colonna M (2004a) TLR9-dependent recognition of MCMV by IPC and DC
generates coordinated cytokine responses that activate antiviral NK cell function. Immunity
21:107-119
Krug A, Luker GD, Barchet W, Leib DA, Akira S, Colonna M (2004b) Herpes simplex virus type
1 activates murine natural interferon-producing cells through toll-like receptor 9. Blood
103:1433-1437
Kurt-Jones EA, Popova L, Kwinn L, Haynes LM, Jones LP, Tripp RA, Walsh EE, Freeman MW,
Golenbock DT, Anderson LJ, Finberg RW (2000) Pattern recognition receptors TLR4 and
CD14 mediate response to respiratory syncytial virus. Nat Immunol 1:398-401
Laroux FS (2004) Mechanisms of inflammation: the good, the bad and the ugly. Front Biosci
9:3156-3162
Larsson S, Soderberg-Naucler C, Moller E (1998) Productive cytomegalovirus (CMV) infection
exclusively in CD13-positive peripheral blood mononuclear cells from CMV-infected individ-
uals: implications for prevention of CMV transmission. Transplantation 65:411-415
Lopper M, Compton T (2004) Coiled-coil domains in glycoproteins B and H are involved in
human cytomegalovirus membrane fusion. J Virol 78:8333-8341
